Phage Therapy - Part B

Erscheinungsjahr 2023
ISBN: 978-0-323-95565-2
Verlag: William Andrew Publishing

Buch, Englisch, Format (B × H): 151 mm x 229 mm, Gewicht: 590 g

Phage Therapy - Part B, Volume 201 covers bacteriophage and their isolation, screening, synthetic phage, diagnostics, directed evolution, host interaction, and more. The book's aim is to highlight a number of aspects of phage in a way that can help students, researchers, clinicians, entrepreneurs and stakeholders perform research. Sections cover Phages for the treatment of Pseudomonas aeruginosa infection, Phage for the treatment of Vibrio cholerae infection, Phages for the treatment of Mycobacterium species, Phage therapy for gut microbiome, Phages as delivery vehicles, Phage display, Unlocking the potential of Phages: Innovative Approaches to harnessing Bacteriophages as Diagnostic Tools for Human Diseases, and more.

Other sections explore Phage display and human disease detection, Bacteriophage as Cargo and its application in nanomedicine, Phage for drug delivery vehicles, Genome editing for phage design and uses for therapeutic applications, Phage for cancer therapy, and Phage for regenerative medicine and cosmetics.

Autoren/Hrsg.

Weitere Mitwirkende

Singh, Vijai

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

1. Phages for treatment Pseudomonas aeruginosa infectionSalsabil Makky, Fatma Abdelrahman, Nouran Rezk, Maheswaran Easwaran, and Ayman El-Shibiny2. Phage for treatment of Vibrio cholerae infectionMilky Mittal, Surbhi Tripathi, Ashok Saini, and Indra Mani3. Phages for the treatment of Mycobacterium speciesChristoffel Johannes Opperman, Justyna Wojno, Wynand Goosen, and Rob Warren4. Phage therapy in gut microbiomeXingyao Chen, Beatriz G. Mendes, Bruno Secchi Alves, and Yi Duan5. Phages as delivery vehicles and phage displaySalsabil Makky, Fatma Abdelrahman, Maheswaran Easwaran, Anan Safwat, and Ayman El-Shibiny6. Unlocking the potential of phages: Innovative approaches to harnessing bacteriophages as diagnostic tools for human diseasesVishnu Kirthi Arivarasan7. Phage Display and Human Disease DetectionSonu Kumari, Krati Singh, Neha Singh, Suphiya Khan, and Ajay Kumar8. Bacteriophage as cargo and its application in nanomedicineVishnu Kirthi Arivarasan and Chitrakshi Consul 9. Phage for drug delivery vehiclesMohit Kumar, Piyush Parkhey, Santosh Kumar Mishra, Prabir Kumar Paul, Avinash Kumar Singh, and Vijai Singh10. Genome editing for phage design and uses for therapeutic applicationsKarthik Loganathan and Baskaran Viswanathan11. Phage for cancer therapyHue Vu Thi, Anh-Dao Ngo, Linh-Thao Tran, and Dinh-Toi Chu12. Phage for regenerative medicine and cosmeticsNhat-Le Bui, Mai Anh Nguyen, Manh-Long Nguyen, Quoc-Cuong Bui, and Dinh-Toi Chu

Über Autor(innen)

Singh, Vijai
Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.